A new study found that the weight loss drug Ozempic can help reduce a stroke patient’s risk of a heart attack or death. The researchers revealed that GLP-1 weight-loss drugs like Ozempic or SGLT2 diabetes medications like Jardiance or Farxiga can help protect people after a stroke. The findings of the study were presented at the American Heart Association’s annual meeting in Chicago and are yet to be published in a peer-reviewed journal.
The results of the study show that patients taking a GLP-1 or SGLT2 drug had a 74% lower risk of death and an 84% lower risk of a heart attack within an average three years after their stroke, according to a report in U.S. News.
The study also says that SGLT2 drugs were also linked to a 67% lower risk of a second stroke. Dr Ali Sheffeh, an internal medicine physician and research scholar at the Mayo Clinic in Rochester, Minnesota and lead researcher said, “Unfortunately, a quarter of people who survive a stroke will have another stroke, and they are also at risk for other cardiovascular events such as a heart attack since many of the risk factors of a stroke are also associated with other forms of heart disease.” Sheffeh in a news release added, “Managing these risks, as well as looking at novel approaches to help lower the chances of another stroke, heart attack or death among this population are all critical steps in increasing stroke survival and improving the quality of life for people who have had a stroke.
” For the study, re.
